Suppr超能文献

高出血风险患者经皮冠状动脉介入治疗后桡动脉远端入路的可行性

Feasibility of Distal Radial Access in High Bleeding Risk Patients Who Underwent Percutaneous Coronary Intervention.

作者信息

Jin In Tae, Roh Ji Woong, Lee Oh-Hyun, Im Eui, Cho Deok-Kyu, Lee Jun-Won, Lee Bong-Ki, Yoo Sang-Yong, Lee Sang Yeub, Kim Chan Joon, Jin Han-Young, Park Jin Sup, Heo Jung Ho, Kim Do Hoi, Lee Jin Bae, Kim Dong-Kie, Bae Jun Ho, Lee Sung-Yun, Lee Seung-Hwan, Kim Yongcheol

机构信息

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea.

出版信息

Korean Circ J. 2025 Apr;55(4):291-301. doi: 10.4070/kcj.2024.0239. Epub 2024 Nov 14.

Abstract

BACKGROUNDS AND OBJECTIVES

The distal radial access (DRA), a potential alternative to the trans-radial approach (TRA), may offer advantages in terms of access site complications due to its smaller vessel diameter, especially for high bleeding risk (HBR) patients. This study aims to investigate the feasibility of DRA in HBR patients.

METHODS

Based on data from the KODRA registry, a prospective, multicenter cohort, this study analyzed 1,586 patients who underwent successful percutaneous coronary intervention (PCI) via DRA. Patients were categorized into HBR and non-HBR groups. The primary endpoint of the study is DRA-related bleeding, and the secondary endpoints of the study are overall access site complications and each component of the access site complications. To reduce the effect of potential confounders, a multivariable adjustment analysis was performed.

RESULTS

The mean age of the total population was 71.1±10.8 years, and 40.3% of patients were female. Both DRA-related bleeding (odds ratio [OR], 1.15; 95% confidence interval [CI], 0.67-1.97; p=0.616) and overall access site complications (OR, 1.08; 95% CI, 0.67-1.72; p=0.761) were not significantly different between the HBR group and non-HBR group after multivariable adjustment. No major bleeding before discharge was observed in both groups. Furthermore, the incidence of distal and conventional radial artery occlusion was less than 1% at 1-month follow-up in both groups.

CONCLUSIONS

Our study results showed the safety of DRA for both DRA-related bleeding and access site complications among HBR patients who underwent PCI.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT04080700.

摘要

背景与目的

桡动脉远端入路(DRA)作为经桡动脉入路(TRA)的一种潜在替代方法,因其血管直径较小,在穿刺部位并发症方面可能具有优势,尤其对于高出血风险(HBR)患者。本研究旨在探讨DRA在HBR患者中的可行性。

方法

基于KODRA注册研究的数据,这是一项前瞻性、多中心队列研究,分析了1586例经DRA成功进行经皮冠状动脉介入治疗(PCI)的患者。患者被分为HBR组和非HBR组。本研究的主要终点是与DRA相关的出血,次要终点是总体穿刺部位并发症以及穿刺部位并发症的各个组成部分。为降低潜在混杂因素的影响,进行了多变量调整分析。

结果

总体人群的平均年龄为71.1±10.8岁,40.3%的患者为女性。多变量调整后,HBR组和非HBR组在与DRA相关的出血(优势比[OR],1.15;95%置信区间[CI],0.67 - 1.97;p = 0.616)和总体穿刺部位并发症(OR,1.08;95% CI,0.67 - 1.72;p = 0.761)方面均无显著差异。两组在出院前均未观察到严重出血。此外,两组在1个月随访时远端和传统桡动脉闭塞的发生率均低于1%。

结论

我们的研究结果表明,DRA对于接受PCI的HBR患者在与DRA相关的出血和穿刺部位并发症方面均具有安全性。

试验注册

ClinicalTrials.gov标识符:NCT04080700。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b97/12046303/793cfef125b0/kcj-55-291-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验